Marc Sinatra's Bioguide Brief Notes:

Topical analyses of companies, mergers 
and issues facing the sector

	May 25, 2011 Why I Wasn't Holding Pharmaxis	Apr 4, 2011 Cellestis' Playing The Ball, Not The Man, Pays Off
Apr 1, 2011 Bouquets For Biota, Bionomics	Mar 30,2011 Valeant Bid Unlikely To Affect Chemgenex	Mar 29, 2011 Chemgenex Going Down - $5.50 ... $2.90 ... 70c
Mar 28, 2011 Avexa's ATC Harder to Kill Than A Cockroach	Dec 8, 2010 Cephalon Swoops On Mesoblast - Good For All	Dec 6, 2010 Bioniche Blue Sky Over Solid Ground
Dec 6, 2010 Chemgenex Revalued From $5.50 To $2.90, Maybe	Dec 3, 2010 Dr George Jessup Starts-Up Bionomics	Nov 24, 2010 Acrux Joins The Revenue PositiveRare Breeds
Sep 13, 2010 Broadvector's 'Very Reasonable' IPO	Sep 13, 2010 Biota, Daiichi Sankyo & A New Generation 'Flu Drug	Sep 9, 2010 Novogen To Be Cash Flow Positive - Duh, Wuh?
Aug 20, 2010 Chemeq - It's Still Alive!	Aug 18, 2010 Phylogica - Is Deal, Is Good	Aug 10, 2010 Acrux, Calzada, Avexa & Looking After Number 1
Jul 8, 2010  Axeva Investors Need To Face Facts	Jun 23, 2010 Pharmaxis 'Missed By That Much' Or Did It?	Jun 2, 2010 Novogen Joins The Failed Phase III Club
May 12, 13, 2010   Mesoblast Takes Angioblast - Victory For All	May 10, 2010 Avexa's Apricitabine - A Busted Flush	Apr 21, 2010 Biota Loses Another Collaborator
Apr 12, 2010 Chemgenex - No News Is Not Good News	Apr 7, 2010 Biologics, Biosimilars & Data Exclusivity 101	Mar 24, 2010 Obamacare Good For Australian Biotechnology
Mar 23, 2010 Chemgenex: Dark Cloud, Silver Lining	Mar 16, 2010 Here's To Acrux, Its Investors & Aussie Biotech	Feb 16, 2010 Quattuordecim Dies Horribilis - Avexa, Chemgenex, CBio
Feb 9, 2010 Chemgenex, The FDA & Tough Questions	Feb 5, 2010 Tough Road Ahead For Avexa's ATC	Dec 14, 2009 Chemgenex's $137m Positive Signal
Nov 19, 2009 Progen - More Truce Than Resolution	Oct 7, 2009 Despite Price, Cytopia-YM Deal Good For Both	Oct 5, 2009 Crunch Time For Avexa's Apricitabine
Sept 25, 2009 Why Is Halcygen Buying Mayne Pharma?	Sept 9, 2009 Chemgenex ASX's Most Undervalued Biotech	Sept 3, 2009 Peplin Not A 5-Banger, Anymore
July 29, 2009 Dia-B, Pallane Fully Underwritten, Or Not?	July 22, 2009 Prima's $25.5 Convertible Note	July 14, 2009 Delist Or Not Delist?
July 3, 2009 Bioguide Brief: Progen - A New Train Coming?	June 30, 2009 Polartechnics, Fermiscan Strapped For Cash And The Wedding's Off	June 22, 2009 Dia-B, Pallane & A Flea In The Ear
May 29, 2009 Bioguide Brief: Dia-B Pallane Merge For '$100m' Viral Test Co	May 21, 2009 Sirtex Free of Dr Bruce Gray, UWA Case; Bioguide Brief: What Gray Case Means For Research	May 18, 2009 Bioguide Brief: Verva, Small Holders And The Unlisted Space
May 13, 2009 Federal Budget	April 20, 2009 Blessing The Polartechnics-Fermiscan Marriage	March 30, 2009 The Progen Prize Goes To .... Medigen?
March 11, 2009 Is That A Whiff Of Cash In The Air ?	March 9, 2009 Progen Kills Avexa Deal; Bioguide Brief: Progen Cops A Kicking	March 3, 2009 Stemcells Inc Buys Stem Cells For $7m; Bioguide Brief: Stem Cell Sells All But Shell
March 2, 2009 Arana And Under-10s Cricket	February 25, 2009 Who Contributes To Solagran's Share Price?	February 16, 2009 Thoratec Buys Heartware For $429m; Bioguide Brief: Deal Hurts Ventracor
February 6, 2009 Progen's Wedding Choices	January 28, 2009 Cytopia's Uncapped Bid For Progen; Bioguide Brief: Cytopia A Better Partner	December 19, 2008 The Metabolic - Polynovo Deal
December 18, 2008 Fair Value IPOs, Cellscreen Direct	December 2, 2008 Genetic Technologies Frees Breast, Ovarian Cancer Tests; Bioguide: GTG & Corporate Philanthropy	November 14, 2008 Progen's Beerworth Review On The Money

 

Contact Marc using the form below